PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, Massachusetts.\', \'Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.\', \'Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.\', \'Harvard-Thorndike Electrophysiology Institute, Division of Cardiovascular Medicine, Beth Israel Deaconess Medical, Boston, Massachusetts.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1001/jamacardio.2020.1834
?:hasPublicationType
?:journal
  • JAMA cardiology
is ?:pmid of
?:pmid
?:pmid
  • 32936252
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.551
?:rankingScore_hIndex
  • 18
is ?:relation_isRelatedTo_publication of
?:title
  • Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19).
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all